KR101440483B1 - Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient - Google Patents
Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient Download PDFInfo
- Publication number
- KR101440483B1 KR101440483B1 KR1020120067900A KR20120067900A KR101440483B1 KR 101440483 B1 KR101440483 B1 KR 101440483B1 KR 1020120067900 A KR1020120067900 A KR 1020120067900A KR 20120067900 A KR20120067900 A KR 20120067900A KR 101440483 B1 KR101440483 B1 KR 101440483B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- fraction
- aldicia
- present
- tincturea
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 92
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 239000004480 active ingredient Substances 0.000 title claims abstract description 30
- 241000722826 Ardisia Species 0.000 title claims description 11
- 230000003712 anti-aging effect Effects 0.000 title description 9
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 38
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 34
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 239000002034 butanolic fraction Substances 0.000 claims abstract description 8
- 239000002038 ethyl acetate fraction Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 11
- 230000007760 free radical scavenging Effects 0.000 abstract description 35
- 235000013402 health food Nutrition 0.000 abstract description 13
- 230000032683 aging Effects 0.000 abstract description 11
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 10
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 description 29
- 229940098465 tincture Drugs 0.000 description 26
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 235000013305 food Nutrition 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 11
- 238000000605 extraction Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- -1 superoxide radicals Chemical class 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 229930003799 tocopherol Natural products 0.000 description 6
- 239000011732 tocopherol Substances 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 5
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 229960001375 lactose Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000012223 aqueous fraction Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 239000002044 hexane fraction Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000002036 chloroform fraction Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000722824 Ardisia crenata Species 0.000 description 1
- 241001645754 Ardisia pusilla Species 0.000 description 1
- 241000556855 Argia eliptica Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000758344 Myrsinaceae Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- LVQSCKUKDKAQGO-UHFFFAOYSA-L disodium;diiodide Chemical compound [Na+].[Na+].[I-].[I-] LVQSCKUKDKAQGO-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940071117 starch glycolate Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 조성물에 관한 것으로, 보다 구체적으로 본 발명의 알디시아 팅크토리아 추출물은 농도의존적으로 DPPH 자유라디칼 소거 활성과 ABTS 자유라디칼 소거 활성을 나타내었으며, 이의 분획물인 에틸아세테이트 및 부탄올 분획물도 탁월한 DPPH 자유라디칼 소거 활성과 ABTS 자유라디칼 소거 활성을 나타내었다. 이에 알디시아 팅크토리아 추출물 또는 이의 분획물이 강한 항산화제로써, 노화방지용 화장료 조성물, 약학적 조성물 및 건강식품용 조성물의 유효성분으로 유용하게 사용될 수 있다.The present invention relates to a method for the treatment of Aldisia tinctoria tinctoria The present invention relates to an antioxidant composition containing an extract or a fraction thereof as an active ingredient. More specifically, the present invention relates to an antioxidant composition comprising DPPH free radical scavenging activity and ABTS free radical scavenging activity, Its ethyl acetate and butanol fractions also showed excellent DPPH free radical scavenging activity and ABTS free radical scavenging activity. Accordingly, the extract of Aldrichia tincturea or a fraction thereof is a strong antioxidant and can be effectively used as an active ingredient of a cosmetic composition for preventing aging, a pharmaceutical composition and a composition for health food.
Description
본 발명은 노화방지용 조성물에 관한 것으로, 구체적으로 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 화장료 조성물, 약학적 조성물 및 건강식품용 조성물에 관한 것이다.
The present invention relates to an antioxidant composition, and more particularly to a composition for preventing aging which comprises Ardisia tinctoria The present invention relates to a cosmetic composition for preventing deterioration, a pharmaceutical composition, and a composition for a health food, which contains an extract or a fraction thereof as an active ingredient.
인체의 노화와 질병을 유발하는 자유 라디칼은 인체 내에서 정상적인 대사과정 중 생물학적 반응으로 형성되며, 세포와 조직에 해로운 독성을 일으켜 여러 가지 질병을 유발하는 것으로 알려져 있다(Folin O & Denis W, 1912, J Biol Chem 12: 239-249). 이러한 유해 자유라디칼을 억제하는 생리작용으로는 산화성 자유라디칼에 전자를 공여하여 산화를 억제하는 전자공여능과 수퍼옥사이드 디스뮤타제(superoxide dismutase; SOD)와 유사한 역할로서 반응성과 파괴성이 매우 큰 수퍼옥사이드 음이온 라디칼(superoxide anion radical)을 정상상태의 산소로 전환 시켜주는 역할이 있다. 강력한 항산화 효과를 가지는 여러 가지 생리활성 성분들은 산화적 스트레스에 의해 발생되는 궤양과 경련의 예방, 위장관의 위액 분비조절과 설사예방, 당뇨예방, 암, 심장병 및 퇴행성 질병들의 예방과 감소에 크게 기여한다고 보고되고 있다(Azuma K et al., 1999, J Agric Food Chem 47: 3963-3966, Ham SS et al., 1997, J Food Sci Nutr 2:155-161). 그리고, 최근 건강에 대한 관심이 높아지면서 다양한 식물자원에서 항암, 항알러지, 항비만, 항산화 및 항균 등의 효과가 있는 기능성 물질을 다량 함유하는 자원을 선발하여, 약으로, 식품첨가제로, 또는 화장품의 원료로 개발하려는 연구가 전 세계적으로 진행되고 있다(Shin DB, et al., 2006, Food Sci Biotechnol., 15: 357-362, Park et al., 2004, Korean J Nutr, 37: 364-372, Kim et al., 2006, Kor J Food Sci. Technol. 38: 799-804, Ali KA et al., 2005, Food Chem., 89: 27-36).
Free radicals that cause aging and disease in humans are known to form in biological reactions during normal metabolic processes in the body, causing harmful toxins to cells and tissues and causing various diseases (Folin O & Denis W, 1912, J Biol Chem 12: 239-249). Physiological actions to inhibit such harmful free radicals include electron donating ability to inhibit oxidation by donating electrons to oxidative free radicals and superoxide anion (SOD), which has a similar reactivity with superoxide dismutase (SOD) It has the role of converting radical (superoxide anion radical) into normal oxygen. Several physiologically active ingredients with strong antioxidant effects contribute to prevention of ulcers and seizures caused by oxidative stress, regulation of gastric secretion and prevention of diarrhea, prevention of diabetes, prevention and reduction of cancer, heart disease and degenerative diseases (Azuma K et < RTI ID = 0.0 > al ., < / RTI > 1999, J Agric Food Chem 47: 3963-3966, Ham SS et al ., 1997, J Food Sci Nutr 2: 155-161). Recently, as interest in health has increased, a resource containing a large amount of a functional substance having various effects such as anticancer, antiallergic, anti-obesity, antioxidant and antibacterial activity has been selected from various plant resources, (Shin DB, et < RTI ID = 0.0 > al ., 2006, Food Sci Biotechnol., 15: 357-362, Park et al al ., 2004, Korean J Nutr, 37: 364-372, Kim et al ., 2006, Kor J Food Sci. Technol. 38: 799-804, Ali KA et al ., 2005, Food Chem., 89: 27-36).
항산화제인 수퍼옥사이드 디스뮤타제(superoxide dismutase; SOD)는 세포의 호흡과정에서 발생한 활성산소 즉, 수퍼옥사이드 라디칼을 과산화수소와 산소로 분해시킨다. 과산화수소는 철이나 동이온과 같은 금속이온과 결합하여 반응을 하게 되면 하이드록시 라디칼이라는 보다 강력한 활성산소가 발생하게 된다. 과산화수소가 금속이온과 반응하기 전에 이를 제거해주는 항산화제인 카탈라아제와 글루타치온 퍼옥시다제가 과산화수소를 물과 이산화탄소로 분해를 시켜준다. 과산화수소를 제거해주는 항산화제가 5%의 과산화수소를 완벽하게 제거를 못 한 나머지 이것이 체내의 금속이온에 반응하여 하이드록시 라디칼로 변해 우리의 몸을 노화시키고 병들어 죽게 하는 것이다. 방사선이나 자외선의 잦은 노출은 과산화수소를 하이드록시 라디칼로 변하게 하여 노화를 촉진시키는데, 이를 지연시키는 방법으로는 항산화제의 복용이 있다. 수퍼옥사이드 라디칼(Superoxide radical, O2 -) 자체는 반응성이 비교적 약하지만, 쉽게 H2O2로 변환되어 결국, 반응성이 강한 하이드록실 라디칼을 생성하거나, 나이트릭 옥사이드(nitric oxide, NO)와 반응하여 반응성이 강한 퍼옥시나이트라이트(peroxy nitrite, ONOO)를 생성하여 SH-그룹의 산화, 단백질 티로신의 질산화(nitration), 지질과산화, DNA 손상 등을 일으키는 원인이 된다.Superoxide dismutase (SOD), an antioxidant, breaks down active oxygen, or superoxide radicals, generated in the respiration process of cells into hydrogen peroxide and oxygen. Hydrogen peroxide reacts with metal ions such as iron or copper ions to generate stronger active oxygen called hydroxy radicals. Catalase and glutathione peroxidase, antioxidants that remove hydrogen peroxide before it reacts with metal ions, decompose hydrogen peroxide into water and carbon dioxide. The antioxidant that removes hydrogen peroxide can not completely remove 5% of hydrogen peroxide, which reacts with metal ions in the body to turn into hydroxy radicals, aging our bodies and causing them to die. Frequent exposure to radiation or ultraviolet light changes the hydrogen peroxide into hydroxy radicals to promote senescence. An antioxidant is a method of delaying this. Superoxide radicals (O 2 - ) themselves are relatively weak in reactivity, but they are easily converted to H 2 O 2 , resulting in hydroxyl radicals that are highly reactive or react with nitric oxide (NO) (Peroxynitrite) (ONOO), which causes oxidation of SH-group, nitration of protein tyrosine, lipid peroxidation, and DNA damage.
현재 항산화능을 측정하기위한 보편적인 방법으로는 biomarker인 자유라디칼의 홀전자가 수산기(-OH)와 반응하여 탈색되는 현상을 이용한 DPPH 혹은 ABTS 자유라디칼 소거 실험법을 많이 이용하고 있다.
Currently, DPPH or ABTS free radical scavenging method is widely used as a universal method for measuring antioxidant ability, in which hole electrons of free radicals, which are biomarkers, react with hydroxyl groups (-OH) and decolorize.
항산화 물질은 동·식물계에 널리 분포되어 있는데, 과일과 채소에 많은 페놀성 화합물, 플라보노이드, 토코페롤, 비타민 C, 셀레늄과 같은 항산화 물질은 지방의 산화를 지연시키거나 방지하며 암 및 심장혈관계 질환 등을 예방, 지연시킴으로써 노화방지에도 중요한 역할을 한다. 식물계에 존재하는 천연 항산화 물질인 토코페롤과 비타민 C는 식품, 의약품 및 화장품 등에 널리 이용되고 있다. 유지 또는 유지함유 식품의 산패는 주로 공기 중의 산소와 결합에 의해 일어나는데, 이를 방지하기 위하여 많은 합성 또는 천연 항산화 물질이 개발되어 왔으나, 그 효과와 경제성 때문에 실제로 많이 사용되고 있는 것은 합성 항산화제이다. 합성 항산화제로는 BHT(Butylated Hydroxy Toluene), BHA(Butylated Hydroxy Anisole), 프로필갈레이트(Propyl Gallate) 등이 있다. 합성 항산화제는 항산화력이 뛰어나고 가격이 저렴하여 상업용 식품에 많이 사용되고 있으나, 인체 부작용 등 안정성에 대한 우려로 그 사용량이 법적으로 규제되어 있다. 토코페롤과 같은 천연 항산화제는 인체에 대하여 안전하기는 하나 단독으로는 산화 연쇄반응 저지 능력이 있고, 가격이 비싼 단점이 있다. 따라서, 최근에는 보다 안전하고 항산화 효과가 뛰어난 천연 항산화제를 개발하기 위한 연구가 활발히 이루어지고 있다.
Antioxidants are widely distributed in plants and plants. Many antioxidants such as phenolic compounds, flavonoids, tocopherols, vitamin C and selenium in fruits and vegetables can delay or prevent the oxidation of fats and cause cancer and cardiovascular diseases Prevention, and delaying the disease. Tocopherol and vitamin C, which are natural antioxidants in the vegetable field, are widely used in foods, medicines and cosmetics. The rancidity of foods containing oil or fat is mainly caused by binding with oxygen in the air. To prevent this, many synthetic or natural antioxidants have been developed. However, synthetic antioxidants are used in practice because of their effectiveness and economy. Examples of synthetic antioxidants include Butylated Hydroxy Toluene (BHT), Butylated Hydroxy Anisole (BHA), and Propyl Gallate. Synthetic antioxidants are widely used in commercial foods because of their excellent antioxidant ability and low cost, but their use is regulated due to concerns about safety, such as human side effects. Natural antioxidants such as tocopherol are safe for the human body, but have the disadvantage that they have the ability to inhibit oxidative chain reaction and are expensive. Therefore, in recent years, researches for the development of natural antioxidants which are more safe and have excellent antioxidative effects have been actively conducted.
한편, 알디시아 팅크토리아(Ardisia tinctoria Pit.)는 Myrsinaceae과에 속하는 식물이며, 민간에서 검정색 염료로 사용되었다고 알려져 있다. 동속식물인 A. crenata , A. pusilla의 경우 항산화활성이 있으며(2008-001634, Japan Patent), A.elliptica 식물에서 분리된 시랑산(syringic acid), 이소람테틴(isorhamnetin), 퀘세틴(quercetin)등의 성분들이 항균활성(살모넬라)을 갖는다는 연구결과(Methin Phadungkit & Omboon Luanratana, 20(7), 693-696, 2006, Natural Product Research) 등 동속식물에 대한 연구결과는 다양한 반면, 알디시아 팅크토리아에 대한 연구나, 성분에 대한 연구는 전혀 보고된 바가 없다.
On the other hand, Ardisia tinctoria Pit. Is a plant belonging to the family Myrsinaceae and is known to be used as a black dye in the civilian area. A. crenata and A. pusilla have antioxidative activities (2008-001634, Japan Patent), syringic acid isolated from A. eliptica plants, isorhamnetin , quercetin (Methin Phadungkit & Omboon Luanratana, 20 (7), 693-696, 2006, Natural Product Research), which have antibacterial activity (Salmonella) No studies have been reported on tincture and its components.
이에, 본 발명자들은 항산화 효과가 우수한 식물을 스크리닝하던 중, 알디시아 팅크토리아의 추출물 및 분획물이 우수한 DPPH(1,1-diphenyl-2-picryl-hydrazyl) 자유라디칼 소거 활성, ABTS(2,2'-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid)) 자유라디칼 소거 활성을 나타내어 탁월한 항산화 효과를 가지고 있음을 확인함으로써, 노화방지용 조성물의 유효성분으로 유용하게 사용될 수 있음을 밝힘으로써 본 발명을 완성하였다.
Thus, the present inventors have found that when extracts and fractions of Aldichia tinctoria are screened for plants having excellent antioxidative effects, excellent DPPH (1,1-diphenyl-2-picryl-hydrazyl) free radical scavenging activity, ABTS (2,2 ' -azinobis- (3-ethylbenzothiazoline-6-sulphonic acid)) free radical scavenging activity and has an excellent antioxidative effect. Thus, the present invention can be effectively used as an active ingredient of an antioxidant composition .
본 발명의 목적은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 화장료 조성물, 약학적 조성물 및 건강식품용 조성물을 제공하는 것이다.
An object of the present invention is to provide an anti-aging cosmetic composition, a pharmaceutical composition and a composition for health food containing an extract of Ardisia tinctoria Pit. Or a fraction thereof as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides an anti-aging cosmetic composition containing an extract of Ardisia tinctoria Pit. Or a fraction thereof as an active ingredient.
또한, 본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 약학적 조성물을 제공한다.In addition, the present invention relates to a method for the treatment of Aldisia tinctoria tinctoria pit.) extract or a fraction thereof as an active ingredient.
아울러, 본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 건강식품용 조성물을 제공한다.
In addition, the present invention relates to the use of a compound of formula tinctoria pit.) extract or a fraction thereof as an active ingredient.
본 발명의 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물은 DPPH 자유라디칼 생성 억제 효과, ABTS 자유라디칼 생성 억제 효과를 나타내어 우수한 항산화 효과를 가지고 있음을 확인함으로써, 노화방지용 화장료 조성물, 약학적 조성물 및 건강식품용 조성물의 유효성분으로 유용하게 사용될 수 있다.
The inventive Ardisia < RTI ID = 0.0 > tinctoria Pit.) Extract or fraction thereof has an excellent antioxidative effect by inhibiting DPPH free radical generation and inhibiting free radical formation of ABTS. Thus, it is possible to provide a cosmetic composition for the prevention of aging, a pharmaceutical composition, and an active ingredient of a composition for health food Can be usefully used.
도 1은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물 제조과정을 나타낸 그림이다.
도 2는 알디시아 팅크토리아 추출물 또는 이의 분획물의 TLC(Thin Layer Chromatography)를 나타낸 그림이다:
T: 알디시아 팅크토리아 추출물;
H: 알디시아 팅크토리아 n-헥산 분획물;
C: 알디시아 팅크토리아 클로로포름 분획물;
E: 알디시아 팅크토리아 에틸아세테이트 분획물;
B: 알디시아 팅크토리아 부탄올 분획물; 및
W: 알디시아 팅크토리아 물 분획물.
도 3은 알디시아 팅크토리아 추출물 또는 이의 분획물의 CAD(Charge Aerosol Detector)를 나타낸 그림이다.
도 4는 알디시아 팅크토리아 추출물의 자유라디칼 소거 활성을 나타낸 그래프이다.
도 5는 알디시아 팅크토리아 추출물의 ABTS 소거활성에 대한 측정결과를 나타낸 그래프이다.Figure 1 is a graphical representation of Ardisia < RTI ID = 0.0 > tinctoria Pit.) Extract or fractions thereof.
Figure 2 shows the TLC (Thin Layer Chromatography) of an extract of Aldrichia tincturea or its fractions:
T: Aldicia tincturea extract;
H: aldicia tincturea n-hexane fraction;
C: aldicia tincturea chloroform fraction;
E: aldicia tincturea ethyl acetate fraction;
B: aldicia tincture butanol fraction; And
W: Aldicia tincture water fraction.
FIG. 3 is a diagram showing a CAD (Charge Aerosol Detector) of an aldicia tincturea extract or a fraction thereof.
4 is a graph showing the free radical scavenging activity of the extract of Aldrichia tinctureia.
5 is a graph showing the measurement results of the ABTS scavenging activity of the aldicia tincturea extract.
이하, 본 발명을 상세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 화장료 조성물을 제공한다.The present invention relates to a method for the treatment of Aldisia tinctoria tinctoria pit.) extract or a fraction thereof as an active ingredient.
상기 노화는 피부노화인 것이 바람직하나 이에 한정하지 않는다.The aging is preferably skin aging, but not always limited thereto.
또한, 본 발명은 알디시아 팅크토리아(Ardisia tinctoria Pit.) 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 화장료 조성물을 제공한다.
In addition, the present invention relates to a method for the treatment of Aldisia tinctoria tinctoria Pit.) Extract or a fraction thereof as an active ingredient.
상기 알디시아 팅크토리아 추출물은 하기의 단계들을 포함하는 제조방법에 의해 제조되는 것이 바람직하나 이에 한정되지 않는다:The aldicia tincturea extract is preferably but not limited to be produced by a method comprising the steps of:
1) 알디시아 팅크토리아(Ardisia tinctoria)에 추출용매를 가하여 추출하는 단계;1) extracting Ardisia tinctoria with an extraction solvent;
2) 단계 1)의 추출물을 여과하는 단계; 및2) filtering the extract of step 1); And
3) 단계 2)의 여과한 추출물을 감압 농축한 후 건조하여 알디시아 팅크토리아의 추출물을 제조하는 단계.3) Concentrating the filtrate obtained in step 2) under reduced pressure, and then drying the extract to prepare an extract of Aldrich tincture.
상기 방법에 있어서, 단계 1)의 알디시아 팅크토리아(Ardisia tinctoria)는 재배한 것 또는 시판되는 것 등 제한 없이 사용할 수 있다. 상기 알디시아 팅크토리아는 잎, 줄기 또는 뿌리가 모두 이용가능하나 이에 한정하지 않는다.In the above method, the step 1) of Ardisia tinctoria ) may be used without limitation, such as cultivated or marketed. The aldicia tincture may be any of leaves, stems or roots, but is not limited thereto.
상기 방법에 있어서, 상기 단계 1)의 추출용매는 물, 알코올 또는 이들의 혼합물을 사용하는 것이 바람직하다. 상기 알코올로는 C1 내지 C2 저급 알코올을 이용하는 것이 바람직하며, 저급 알코올로는 에탄올 또는 메탄올을 이용하는 것이 바람직하고, 메탄올을 이용하는 것이 가장 바람직하나, 이에 한정하지 않는다. 추출방법으로는 진탕추출, Soxhlet 추출 또는 환류 추출을 이용하는 것이 바람직하나 이에 한정되지 않는다. 상기 추출용매를 건조된 알디시아 팅크토리아 분량에 1 내지 10배 첨가하여 추출하는 것이 바람직하고, 2 내지 3배 첨가하여 추출하는 것이 더욱 바람직하나, 이에 한정하지 않는다. 추출온도는 20 내지 100℃인 것이 바람직하고, 20 내지 40℃인 것이 바람직하나, 이에 한정하지 않는다. 또한, 추출시간은 10 내지 48시간인 것이 바람직하며, 15 내지 30시간인 것이 더욱 바람직하나 이에 한정하지 않는다. 아울러, 추출 회수는 1 내지 5회인 것이 바람직하며, 3 내지 4회 반복 추출하는 것이 더욱 바람직하나 이에 한정되는 것은 아니다. In the above method, it is preferable to use water, an alcohol or a mixture thereof in the extraction solvent of the step 1). As the alcohol, a C 1 to C 2 lower alcohol is preferably used. As the lower alcohol, ethanol or methanol is preferably used, and methanol is most preferably used, but not limited thereto. As the extraction method, it is preferable to use shaking extraction, Soxhlet extraction or reflux extraction, but it is not limited thereto. Preferably, the extraction solvent is added by 1 to 10 times the amount of dried aldicia tinctoria, more preferably by 2 to 3 times, but not always limited thereto. The extraction temperature is preferably 20 to 100 ° C, and preferably 20 to 40 ° C, but is not limited thereto. In addition, the extraction time is preferably 10 to 48 hours, more preferably 15 to 30 hours, but is not limited thereto. In addition, the extraction number is preferably 1 to 5 times, more preferably 3 to 4 times, but is not limited thereto.
상기 방법에 있어서, 단계 3)의 감압농축은 진공감압농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조하는 것이 바람직하나 이에 한정하지 않는다.In the above method, it is preferable to use a vacuum decompression concentrator or a vacuum rotary evaporator for the decompression concentration in step 3), but it is not limited thereto. The drying is preferably performed under reduced pressure, vacuum drying, boiling, spray drying or freeze drying, but not always limited thereto.
또한, 상기 알디시아 팅크토리아 추출물의 분획물은 다음과 같이 제조되는 것이 바람직하나 이에 한정하지 않는다.In addition, the fraction of the above-mentioned aldicia tincturea extract is preferably prepared as follows, but it is not limited thereto.
1) 알디시아 팅크토리아 추출물을 물에 현탁한 후, n-헥산을 가하여 n-헥산층을 분리하는 단계;1) suspending the extract of Aldrichia tinctureia in water, separating the n-hexane layer by adding n-hexane;
2) 단계 1)의 남은 물층에 클로로포름을 가하여 클로로포름 층을 분리하는 단계;2) adding chloroform to the remaining water layer of step 1) to separate the chloroform layer;
3) 단계 2)의 남은 물층에 에틸아세테이트를 가하여 에틸아세테이트 층을 분리하는 단계; 3) adding ethyl acetate to the remaining water layer of step 2) to separate the ethyl acetate layer;
4) 단계 3)의 남은 물층에 부탄올을 가하여 부탄올 층을 분리하는 단계; 및4) separating the butanol layer by adding butanol to the remaining water layer of step 3); And
5) 단계 4)의 남은 물층에 물 분획물을 분리하는 단계.5) separating the water fraction from the remaining water layer of step 4).
상기 방법에 있어서, 상기 유기용매는 노르말-헥산, 클로로포름, 에틸아세테이트 또는 노르말-부탄올인 것이 바람직하나 이에 한정하지 않는다. 상기 분획물은 상기 알디시아 팅크토리아 추출물로부터 분획 과정을 1 내지 5회, 바람직하게는 3회 반복하여 수득할 수 있고, 분획 후 감압 농축하는 것이 바람직하나 이에 한정하지 않는다.In the above method, the organic solvent is preferably but not limited to n-hexane, chloroform, ethyl acetate or n-butanol. The fraction may be obtained by repeating the fractionation process from the aldicia tincturea
상기 유기용매는 에틸아세테이트 또는 부탄올인 것이 보다 바람직하다.More preferably, the organic solvent is ethyl acetate or butanol.
본 발명의 구체적인 실시예에서, 알디시아 팅크토리아 추출물의 항산화 효과를 확인하기 위하여, DPPH 자유라디칼 소거 활성을 1,1-디페닐-2-피클릴-히드라질(1,1-diphenyl-2-picryl-hydrazyl, DPPH, Sigma) 방법으로 측정한 결과, 알디시아 팅크토리아 추출물이 농도의존적으로 DPPH 자유라디칼의 소거 활성을 나타내는 것을 확인하였다(도 4 참조).In a specific example of the present invention, in order to confirm the antioxidative effect of the aldicia tincturea extract, the DPPH free radical scavenging activity was measured by using 1,1-diphenyl-2- picryl-hydrazyl, DPPH, Sigma). As a result, it was confirmed that the aldicia tincturea extract showed DPPH free radical scavenging activity in a concentration-dependent manner (see FIG. 4).
또한, 본 발명의 또 다른 구체적인 실시예에서, 알디시아 팅크토리아 추출물의 항산화 효과를 확인하기 위하여, 알디시아 팅크토리아 추출물의 다양한 농도에 따른 ABTS 자유라디칼 소거 활성을 측정한 결과, 알디시아 팅크토리아 추출물이 농도의존적으로 ABTS 자유라디칼의 소거 활성을 나타내는 것을 확인하였다(도 5 참조).Further, in another specific example of the present invention, in order to confirm the antioxidative effect of the extract of the aldicia tincturea, the ABTS free radical scavenging activity according to various concentrations of the aldicia tincturea extract was measured. As a result, the aldicia tincturea extract Showed ABTS free radical scavenging activity in a concentration-dependent manner (see FIG. 5).
또한, 본 발명의 또 다른 구체적인 실시예에서, 알디시아 팅크토리아 추출물 또는 이의 분획물의 TLC 조사 및 UPLC 조사를 수행하였다(도 2 및 도 3 참조).Further, in another specific example of the present invention, TLC investigation and UPLC irradiation of the aldicia tincturea extract or its fractions were performed (see Figs. 2 and 3).
또한, 본 발명의 또 다른 구체적인 실시예에서, 알디시아 팅크토리아 분획물의 DPPH 및 ABTS 자유라디칼 소거능을 확인한 결과, 알디시아 팅크토리아 분획물은 DPPH 및 ABTS 자유라디칼 소거능이 우수한 것을 확인하였으며, 특히 알디시아 팅크토리아 에틸아세테이트 및 부탄올 분획물이 DPPH 자유라디칼 소거 효과가 현저히 높고, ABTS 자유라디칼의 경우 전 분획물에 걸쳐 소거 효과가 현저히 우수한 것을 확인하였다(표 1 참조). In another specific example of the present invention, DPPH and ABTS free radical scavenging activities of the aldicia tincture fractions were confirmed. The aldicia tincture fractions were found to be excellent in DPPH and ABTS free radical scavenging ability, It was confirmed that the DPPH free radical scavenging effect of the thioacetic acid and butanol fractions was remarkably high and the ABTS free radical scavenging effect was remarkably excellent in all the fractions (see Table 1).
따라서, 본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물은 현저한 DPPH 자유라디칼 소거 활성 및 ABTS 자유라디칼 소거 활성을 나타내어 탁월한 항산화 효과를 가지므로 노화방지용 화장료 조성물 또는 항산화용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
Therefore, the aldicia tincturea extract of the present invention or its fractions exhibits remarkable DPPH free radical scavenging activity and ABTS free radical scavenging activity and has an excellent antioxidative effect, so that it is useful as an active ingredient of an anti-aging cosmetic composition or antioxidative cosmetic composition .
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition may be in the form of a solution, a gel, a solid or a paste anhydrous product, an emulsion obtained by dispersing an oil phase in water, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome) A cream, a skin, a lotion, a powder, an ointment, a spray, or a cone stick. It can also be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.The cosmetic composition may further contain, in addition to the aldicia tincture extract of the present invention or its fractions, a lipid, an organic solvent, a solubilizer, a thickening agent and a gelling agent, a softener, an antioxidant, a suspending agent, a stabilizer, , A perfume, a surfactant, water, an ionic or nonionic emulsifier, a filler, a sequestering and chelating agent, a preservative, a vitamin, a barrier, a wetting agent, a essential oil, a dye, a pigment, a hydrophilic or lipophilic active agent, Or any other ingredient conventionally used in cosmetics. The cosmetic compositions of the present invention may also contain adjuvants commonly used in the cosmetics field.
본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 추출물이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the aldicia tincturea extract of the present invention or the fraction thereof, the extract of the present invention is added to the cosmetic composition usually contained in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight .
본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.
When the aldicia tincture extract of the present invention or a fraction thereof is used as an external preparation for skin, it may further contain a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, a softener, an antioxidant, a suspending agent, a stabilizer, ), Perfumes, surfactants, water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipids Or any other ingredient conventionally used in external preparations for skin. The present invention also relates to a cosmetic composition, In addition, the components can be introduced in amounts commonly used in the dermatology field.
또한, 본 발명은 알디시아 팅크토리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 약학적 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for preventing aging comprising an aldicia tincturea extract or a fraction thereof as an active ingredient.
상기 노화는 피부노화인 것이 바람직하나 이에 한정하지 않는다. The aging is preferably skin aging, but not always limited thereto.
또한, 본 발명은 알디시아 팅크토리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 약학적 조성물을 제공한다.The present invention also provides a pharmaceutical composition for antioxidant comprising an aldicia tincturea extract or a fraction thereof as an active ingredient.
본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물은 현저한 DPPH 자유라디칼 소거 활성 및 ABTS 자유라디칼 소거 활성을 나타내어 탁월한 항산화 효과를 가지므로 노화방지용 약학적 조성물 또는 항산화용 약학적 조성물의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
The aldicia tincturea extract of the present invention or its fractions exhibits remarkable DPPH free radical scavenging activity and ABTS free radical scavenging activity and has an excellent antioxidative effect and is therefore useful as an active ingredient of an anti-aging pharmaceutical composition or an antioxidant pharmaceutical composition .
본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물을 함유하는 조성물은 상기 성분에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다. The composition containing the aldicia tincturea extract of the present invention or a fraction thereof may further contain one or more active ingredients which exhibit the same or similar functions in addition to the above components.
본 발명의 조성물은 약제학적으로 허용 가능한 첨가제를 더 포함할 수 있으며, 이때 약제학적으로 허용 가능한 첨가제로는 전분, 젤라틴화 전분, 미결정셀룰로오스, 유당, 포비돈, 콜로이달실리콘디옥사이드, 인산수소칼슘, 락토스, 만니톨, 엿, 아라비아고무, 전호화전분, 옥수수전분, 분말셀룰로오스, 히드록시프로필셀룰로오스, 오파드라이, 전분글리콜산나트륨, 카르나우바 납, 합성규산알루미늄, 스테아린산, 스테아린산마그네슘, 스테아린산알루미늄, 스테아린산칼슘, 백당, 덱스트로스, 소르비톨 및 탈크 등이 사용될 수 있다. 본 발명에 따른 약제학적으로 허용 가능한 첨가제는 상기 조성물에 대해 0.1 ~ 90 중량부 포함되는 것이 바람직하나 이에 한정되는 것은 아니다.The composition of the present invention may further comprise a pharmaceutically acceptable additive, wherein pharmaceutically acceptable additives include starch, gelatinized starch, microcrystalline cellulose, lactose, povidone, colloidal silicon dioxide, calcium hydrogen phosphate, lactose Starch glycolate, sodium starch glycolate, carnauba wax, synthetic aluminum silicate, stearic acid, magnesium stearate, aluminum stearate, calcium stearate, calcium stearate, , White sugar, dextrose, sorbitol and talc. The pharmaceutically acceptable additives according to the present invention are preferably included in the composition in an amount of 0.1 to 90 parts by weight, but are not limited thereto.
즉, 본 발명의 조성물은 실제 임상 투여 시에 경구 및 비경구의 여러 가지 제형으로 투여될 수 있는데, 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 알디시아 팅크토리아 추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(Calcium carbonate), 수크로스(Sucrose), 락토오스(Lactose) 또는 젤라틴 등을 섞어 조제될 수 있다. 또한 단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용될 수 있다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제 및 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함될 수 있다. 비수성용제, 현탁용제로는 프로필렌글리콜(Propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.That is, the composition of the present invention can be administered in various formulations of oral and parenteral administration at the time of actual clinical administration. In the case of formulation, a diluent such as a filler, an extender, a binder, a wetting agent, a disintegrant, . ≪ / RTI > Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, Sucrose, Lactose, Gelatin, or the like. In addition to simple excipients, lubricants such as magnesium stearate talc may also be used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions and syrups, and various excipients such as wetting agents, sweetening agents, fragrances, preservatives and the like may be included in addition to water and liquid paraffin, which are simple diluents commonly used . Formulations for parenteral administration may include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used as the non-aqueous solvent and suspension agent. Examples of suppository bases include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin, and the like.
본 발명의 조성물은 목적하는 방법에 따라 경구 투여하거나 비경구 투여할 수 있으며, 비경구 투여시 피부 외용 또는 복강내주사, 직장내주사, 피하주사, 정맥주사, 근육내 주사 또는 흉부내 주사 주입방식을 선택하는 것이 바람직하다. 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설율 및 질환의 중증도 등에 따라 그 범위가 다양하다.The composition of the present invention may be administered orally or parenterally in accordance with the intended method, and may be administered orally, parenterally or intraperitoneally, rectally, subcutaneously, intravenously, intramuscularly, . The dosage varies depending on the patient's body weight, age, sex, health condition, diet, administration time, administration method, excretion rate, and disease severity.
본 발명의 조성물의 투여량은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설율 및 질환의 중증도에 따라 그 범위가 다양하며, 일일 투여량은 알디시아 팅크토리아 추출물의 양을 기준으로 0.0001 내지 100 ㎎/㎏이고, 바람직하게는 0.001 내지 10 ㎎/㎏이며, 하루 1 ~ 6 회 투여될 수 있다.The dosage of the composition of the present invention varies depending on the patient's body weight, age, sex, health condition, diet, administration time, administration method, excretion rate, and severity of disease, and the daily dose is the daily dose of Aldicia tincturea extract Kg, preferably 0.001 to 10 mg / kg, and may be administered 1 to 6 times a day.
본 발명의 조성물은 단독으로, 또는 수술, 방사선 치료, 호르몬 치료, 화학 치료 및 생물학적 반응 조절제를 사용하는 방법들과 병용하여 사용할 수 있다.
The composition of the present invention may be used alone or in combination with methods using surgery, radiation therapy, hormone therapy, chemotherapy, and biological response modifiers.
또한, 본 발명은 알디시아 팅크토리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 건강식품용 조성물을 제공한다.The present invention also provides a composition for anti-aging health food comprising an aldicia tincturea extract or a fraction thereof as an active ingredient.
상기 노화는 피부노화인 것이 바람직하나 이에 한정하지 않는다.The aging is preferably skin aging, but not always limited thereto.
또한, 본 발명은 알디시아 팅크토리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 건강식품용 조성물을 제공한다.The present invention also provides a composition for health food for antioxidation containing an aldicia tincturea extract or a fraction thereof as an active ingredient.
본 발명의 알디시아 팅크토리아 추출물 또는 이의 분획물은 현저한 DPPH 자유라디칼 소거 활성 및 ABTS 자유라디칼 소거 활성을 나타내어 탁월한 항산화 효과를 가지므로 노화방지용 건강식품 또는 항산화용 건강식품의 유효성분으로 유용하게 사용될 수 있음을 알 수 있다.
INDUSTRIAL APPLICABILITY The extract of the present invention or the fraction thereof exhibits a remarkable DPPH free radical scavenging activity and an ABTS free radical scavenging activity and thus has an excellent antioxidative effect and thus can be effectively used as an active ingredient of anti-aging health food or antioxidant health food .
본 발명의 건강식품은 알디시아 팅크토리아 추출물 또는 이의 분획물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다.The health food of the present invention may be used as it is, or may be used in combination with other food or food ingredients, and may be suitably used according to conventional methods.
상기 건강식품의 종류에는 특별한 제한은 없다. 상기 알디시아 팅크토리아 추출물 또는 이의 분획물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the health food. Examples of foods to which the Aldricha tincturea extract or its fractions can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, , Beverages, tea, drinks, alcoholic beverages, and vitamin complexes, all of which include healthy foods in a conventional sense.
본 발명의 건강음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.01 ~ 0.04 g, 바람직하게는 약 0.02 ~ 0.03 g 이다.The health beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 건강식품은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일주스, 과일주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부당 0.01 ~ 0.1 중량부의 범위에서 선택되는 것이 일반적이다.
In addition to the above, the health food of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acids and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, , A carbonating agent used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not critical, but is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
또한, 본 발명은 약학적으로 유효한 양의 알디시아 팅크토리아 추출물 또는 이의 분획물을 유효성분으로 함유하는 약학적 조성물을 개체에 투여하는 단계를 포함하는 노화억제 방법을 제공한다.The present invention also provides a method of inhibiting senescence comprising the step of administering to a subject a pharmaceutical composition comprising a pharmaceutically effective amount of an aldicia tincturea extract or a fraction thereof as an active ingredient.
상기 노화는 피부노화인 것이 바람직하나 이에 한정하지 않는다.The aging is preferably skin aging, but not always limited thereto.
상기 약학적으로 유효한 양이란 0.00001 내지 10 mg/kg이고, 바람직하게는 0.0001 내지 1 mg/kg이나 이에 한정하지 않는다. 투여량은 특정 환자의 체중, 연령, 성별, 건강상태, 식이, 투여기간, 투여방법, 제거율, 질환의 중증도 등에 따라 변화될 수 있다. The pharmaceutically effective amount is 0.00001 to 10 mg / kg, preferably 0.0001 to 1 mg / kg, but is not limited thereto. The dose may vary depending on the weight, age, sex, health condition, diet, administration period, method of administration, rate of elimination, severity of disease, and the like of a particular patient.
상기 개체는 척추동물이고 바람직하게는 포유동물이며, 그보다 바람직하게는 쥐, 토끼, 기니아피크, 햄스터, 개, 고양이와 같은 실험동물이고, 가장 바람직하게는 침팬지, 고릴라와 같은 유인원류 동물이다. The subject is a vertebrate animal, preferably a mammal, more preferably an experimental animal such as a mouse, a rabbit, a guinea pig, a hamster, a dog or a cat, and most preferably an ape-like animal such as a chimpanzee or a gorilla.
상기 투여 방법은 경구 또는 비경구가 바람직하며, 피부 도포가 가장 바람직하다.
The above administration method is preferably oral or parenteral, and skin application is most preferred.
이하, 본 발명을 실시예, 실험예 및 제조예에 의하여 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples, Experimental Examples and Production Examples.
단, 하기 실시예, 실험예 및 제조예는 본 발명을 구체적으로 예시하는 것일 뿐, 본 발명의 내용이 실시예, 실험예 및 제조예에 의해 한정되는 것은 아니다.
However, the following Examples, Experimental Examples and Preparation Examples are merely illustrative of the present invention, and the contents of the present invention are not limited by Examples, Experimental Examples and Production Examples.
<< 실시예Example 1> 1> 알디시아Aldishia 팅크토리아Tincture 추출물의 제조 Preparation of extract
본 발명의 알디시아 팅크토리아 추출물은 한국생명공학연구원 해외생물소재허브센터의 해외식물추출물은행에서 구입하였으며 한국생명공학연구원 식물표본관(KRIB, Herbarium of the Korea Research Institute of Bioscience and Biotechnology)에 증거표본(KRIB 0027026)이 보관되어 있다. 추출과정을 살펴보면, 알디시아 팅크토리아(잎, 어린가지, 꽃)를 건조한 후, 분쇄된 분말시료 113 g을 메탄올 1 ℓ를 가한 후 초음파추출기(SDN-900H, SD-ULTRASONIC CO., LTD)를 이용하여 상온에서 30회(40KHz, 15분 추출-120분 정지) 반복추출하였다. 그런 다음 여과하여 감압농축한 후, 알디시아 팅크토리아 메탄올 추출물(이하 “알디시아 팅크토리아 추출물”이라 함) 10.33 g을 수득하였다.
The aldicia tincturea extract of the present invention was purchased from the overseas plant extract bank of the International Biological Material Hub Center, Korea Research Institute of Bioscience and Biotechnology (KRIB, Korea Research Institute of Bioscience and Biotechnology) KRIB 0027026). After drying the aldicia tincturea (leaves, young branches, flowers), 113 g of the pulverized powder sample was added with 1 L of methanol, and the mixture was sonicated with an ultrasonic wave extractor (SDN-900H, SD-ULTRASONIC CO., LTD) And extracted repeatedly at room temperature for 30 times (40 KHz, 15 minutes extraction - 120 minutes). Then, the mixture was filtered and concentrated under reduced pressure. 10.33 g of an extract of aldicia tincture methanol (hereinafter referred to as "aldicia tinctoria extract") was obtained.
<< 실시예Example 2> 2> 알디시아Aldishia 팅크토리아의Tincture 용매 menstruum 분획물Fraction 제조 Produce
상기 <실시예 1>에서 얻어진 알디시아 팅크토리아 추출물 중 450 mg 에 증류수를 첨가하여 현탁시키고, 동량의 n-헥산을 가하여 혼합 후 n-헥산가용성 분획부와 물가용성 분획부를 분리하였으며, 이를 3회 실시하여 여과, 감압농축하여 n-헥산 분획물 90.4 mg을 수득하였다. 그런 다음, 상기 n-헥산 분획물을 제거하고 남은 물층에 클로로포름을 동량 가하여 같은 방법으로 클로로포름 분획물 22.0 mg 수득하였고, 다시 남은 물층에 에틸아세테이트를 동량 가하여 같은 방법으로 에틸아세테이트 분획물 44.8 mg을 수득하였으며, 또다시 남은 물층에 부탄올을 동량 가하여 동일한 방법으로 부탄올 분획물 57.6 mg을 수득하였으며, 남은 물층을 농축하여 물 분획물 205.2 mg을 수득하였다(도 1).
To 450 mg of the aldicia tincturea extract obtained in Example 1, distilled water was added to suspend, and the same amount of n-hexane was added to the mixture. The n-hexane soluble fraction and the water soluble fraction were separated, Filtration and concentration under reduced pressure gave 90.4 mg of n-hexane fraction. Then, the n-hexane fraction was removed and chloroform was equally added to the remaining water layer to obtain 22.0 mg of chloroform fraction. The remaining water layer was equilibrated with ethyl acetate to obtain 44.8 mg of an ethyl acetate fraction, and To the remaining water layer was added an equal amount of butanol. In the same manner, 57.6 mg of a butanol fraction was obtained. The remaining water layer was concentrated to obtain 205.2 mg of a water fraction (FIG. 1).
<< 실시예Example 3> 3> 알디시아Aldishia 팅크토리아Tincture 추출물 또는 이의 Extract or its 분획물의Fraction TLCTLC 조사 Research
상기 <실시예 1>과 <실시예 2>에서 얻어진 알디시아 팅크토리아 추출물과 분획물을 10 mg/ml의 농도로 메탄올에 녹인 후 실리카겔 박층 크로마토그래피(TLC Silica gel 60 F254, Merck)를 시행하여 비극성물질들을 확인하였다. 전개용매로는 n-헥산: 아세톤의 비율이 2 : 1인 혼합용매로 하였다. 또한, 극성물질들을 확인해 보기 위해 실리카겔 역상 크로마토그래피(TLC Silica gel 60 RP-18 F254S, Merck)를 실시하였고, 전개용매는 메탄올 50%로 하였다(도 2).
The aldicia tincturea extract and the fractions obtained in Example 1 and Example 2 were dissolved in methanol at a concentration of 10 mg / ml and subjected to silica gel thin layer chromatography (TLC Silica gel 60 F 254 , Merck) Non-polar materials were identified. As a developing solvent, a mixed solvent of n-hexane: acetone at a ratio of 2: 1 was used. Silica gel reverse phase chromatography (
<< 실시예Example 4> 4> 알디시아Aldishia 팅크토리아의Tincture 추출물 또는 이의 Extract or its 분획물의Fraction UPLCUPLC 분석 analysis
상기 <실시예 1>과 <실시예 2>에서 얻어진 알디시아 팅크토리아 추출물과 분획물을 10mg/ml로 메탄올에 녹인 후 0.2 um의 membrane filter로 여과하였다. UPLC는 Waters Acquity UPLC 시스템을 이용하였으며, 컬럼은 ACQUITY UPLCTMBEHC18(10mmⅩ 2.1 mm, i.d., 1.7μm, waters, USA)을 35℃에서 사용하였으며, 이동상 A는 물과 formic acid (100:0.1, v/v)로 이동상 B는 acetonitril과 formic acid (100:0.1,v/v)로 하여 초기에 이동상 B를 10%로 1분 동안 유지시킨 후, 5분까지 45%로 증가, 7.5분까지 100%로 이동상 B를 증가시켜 분석한 후, 이동상 B를 100%로 9분까지 유지시키고, 9.5분까지 이동상 B를 10%로 낮추고 11분까지 10%로 안정화시켜 분석에 사용하였다. 이동상의 유속량은 0.4 ㎖/min 그리고 시료 주입량은 3 ㎕로 하였다. The aldicia tincturea extract and fractions obtained in Examples 1 and 2 were dissolved in methanol at a concentration of 10 mg / ml and filtered through a 0.2-μm membrane filter. UPLC was performed using a Waters Acquity UPLC system and the columns were equipped with ACQUITY UPLC ™ BEHC 18 (10 mm × 2.1 mm, id, 1.7 μm, waters, USA) at 35 ° C., mobile phase A with water and formic acid The mobile phase B was initially maintained at 10% for 1 min with acetonitrile and formic acid (100: 0.1, v / v) and then increased to 45% for 5 min and 100 %, Mobile phase B was maintained at 100% for 9 minutes, mobile phase B was lowered to 10% for 9.5 minutes, and stabilized at 10% for 11 minutes. The flow rate of the mobile phase was 0.4 ml / min and the sample injection volume was 3 μl.
CAD(Charge Aerosol Detector)는 UPLC로부터 분리되어진 물질들에 전하(Charge)를 붙여주어 그 전하를 측정하는 detector로써 크로마토그래피 형식으로 물질의 상대적 함량과 분리도를 확인해 볼 수 있다 (도 3). The CAD (Charge Aerosol Detector) is a detector that measures the charge by attaching a charge to materials separated from the UPLC. The relative content and the degree of separation of the material can be confirmed by a chromatographic method (FIG. 3).
<< 실험예Experimental Example 1> 1> 알디시아Aldishia 팅크토리아Tincture 추출물의 Extract DPPHDPPH 자유라디칼Free radical 소거 활성 확인 Verify erase activity
상기 <실시예 1>의 알디시아 팅크토리아 추출물에 대하여 자유라디칼 소거 활성을 1,1-디페닐-2-피크릴-히드라질(1,1-diphenyl-2-picryl-hydrazyl, DPPH, Sigma) 방법으로 측정하였다. The free radical scavenging activity of the aldicia tincturea extract of Example 1 was measured using 1,1-diphenyl-2-picryl-hydrazyl (DPPH, Sigma) .
구체적으로, 자유라디칼 소거 활성 측정에는 에탄올에 잘 녹인 0.15 mM의 DPPH 용액 90 ㎕을 96 웰 플레이트에 넣고, 상기 추출물을 2.5, 5, 10, 20, 40 및 80 ㎍/㎖의 농도로 각각 분주하여, 상온에서 20분간 방치한 후, ELISA 리더(reader)로 517 nm에서 흡광도를 측정하였다. 자유라디칼 소거 활성(%)은 하기의 수학식 1로 산출하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 합성 항산화제인 BHA와 천연항산화제인 토코페롤을 처리한 군을 양성대조군으로 사용하였다.
Specifically, for measurement of free radical scavenging activity, 90 μl of a 0.15 mM DPPH solution well dissolved in ethanol was placed in a 96-well plate, and the extract was divided into 2.5, 5, 10, 20, 40 and 80 μg / , Left at room temperature for 20 minutes, and then measured for absorbance at 517 nm with an ELISA reader. The free radical scavenging activity (%) was calculated by the following equation (1). At this time, the group treated with DMSO was used as a negative control, the group treated with BHA, a synthetic antioxidant, and tocopherol, a natural antioxidant, were used as positive control.
A: 본 발명의 알디시아 팅크토리아 추출물을 처리하지 않은 음성대조군의 흡광도; 및A: Absorbance of negative control not treated with the aldicia tincture extract of the present invention; And
B: 본 발명의 알디시아 팅크토리아 추출물을 처리한 실험군의 흡광도.
B: Absorbance of the test group treated with the aldicia tincture extract of the present invention.
그 결과, 도 4에 나타낸 바와 같이, 알디시아 팅크토리아 추출물에 대한 DPPH 자유라디칼 소거 활성을 측정한 결과, 알디시아 팅크토리아 추출물의 처리 농도에 의존적으로 DPPH 자유라디칼 소거 활성을 나타냄을 확인하였고, 양성대조군인 BHA와 토크페롤과 비교하여 우수한 DPPH 자유라디칼 소거활성을 나타내는 것을 확인하였다(도 4).
As a result, as shown in FIG. 4, the DPPH free radical scavenging activity of the extract of Aldrichia tinctoria was measured, and it was confirmed that DPPH free radical scavenging activity was dependent on the treatment concentration of the Aldicia tincturea extract. And showed excellent DPPH free radical scavenging activity as compared to the control groups BHA and tocopherol (Fig. 4).
<< 실험예Experimental Example 2> 2> 알디시아Aldishia 팅크토리아Tincture 추출물의 Extract ABTSABTS 자유라디칼Free radical 소거 활성 확인 Verify erase activity
상기 <실시예 1>의 알디시아 팅크토리아 추출물을 이용하여 ABTS 자유라디칼 소거 활성을 확인하였다. The ABTS free radical scavenging activity was confirmed using the aldicia tincturea extract of Example 1 above.
구체적으로, ABTS 자유라디칼 소거 활성은 ABTS와 포타슘 퍼설페이트(potassium persulfate)를 각각 7 mM과 2.45 mM의 최종농도가 되도록 혼합한 후, 암소에서 12시간 방치하여 ABTS 라디칼을 형성시켰다. 이를 734 nm에서 흡광도가 0.7이 되도록 증류수로 희석한 후 96 웰 플레이트에 분주하고, 여기에 시료를 2.5, 5, 10, 20, 40 및 80 ㎍/㎖의 농도로 분주한 후, 상온의 암소에서 7분간 반응시켰다. 흡광도는 734 nm에서 마이크로플레이트 측정기를 이용하여 측정하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 합성 항산화제인 BHA와 토크페놀을 처리한 군을 양성대조군으로 사용하였다.Specifically, ABTS free radical scavenging activity was obtained by mixing ABTS and potassium persulfate to a final concentration of 7 mM and 2.45 mM, respectively, and then left in a dark place for 12 hours to form an ABTS radical. This was diluted with distilled water to an absorbance of 0.7 at 734 nm and dispensed into 96-well plates. The samples were dispensed at concentrations of 2.5, 5, 10, 20, 40 and 80 / / And reacted for 7 minutes. Absorbance was measured using a microplate meter at 734 nm. At this time, the group treated with DMSO was used as a negative control, and the group treated with synthetic antioxidant BHA and tokophenol was used as a positive control.
그 결과, 도 5에서 나타낸 바와 같이 알디시아 팅크토리아 추출물에 대한 ABTS 자유라디칼 소거 활성을 측정한 결과, 알디시아 팅크토리아 추출물의 처리 농도에 의존적으로 ABTS 자유라디칼 소거 활성을 나타냄을 확인하였고, 양성대조군인 BHA와 토크페롤과 비교하여 유사한 ABTS 라디칼 소거활성을 나타내는 것을 확인하였다(도 5).
As a result, as shown in FIG. 5, the ABTS free radical scavenging activity of the extract of Aldicia tinctureia was measured, and it was confirmed that ABTS free radical scavenging activity was dependent on the treatment concentration of Aldicia tincturea extract. (BHA) and tocopherol (Fig. 5).
<< 실험예Experimental Example 3> 3> 알디시아Aldishia 팅크토리아Tincture 용매 menstruum 분획물의Fraction DPPHDPPH 및 And ABTSABTS 자유라디칼Free radical 소거능Scatters
상기 <실시예 2>에서 분획한 용매별 n-헥산, 클로로포름, 에틸아세테이트, 부탄올, 물 분획물에 대해 <실험예 1> 및 <실험예 2>와 동일한 방법으로 DPPH 및 ABTS 자유라디칼 소거능을 측정하였다. DPPH and ABTS free radical scavenging activity was measured for n-hexane, chloroform, ethyl acetate, butanol, and water fractions by the solvent in Example 2, in the same manner as Experimental Example 1 and Experimental Example 2 .
구체적으로, 상기 분획한 각 분획물은 40 ㎍/㎖의 농도로 각각 분주하여, 상온에서 반응시킨 후, 마이크로플레이트 흡광기로 흡광도를 측정하였다. 이때, DMSO를 처리한 군을 음성대조군으로, 천연항산화제인 a-토코페롤과 아스코르브산을 처리한 군과 합성항산화제인 BHA를 처리한 군을 양성대조군으로 사용하였다. Specifically, each fraction was fractionated at a concentration of 40 μg / ml, reacted at room temperature, and then absorbance was measured with a microplate absorber. At this time, the group treated with DMSO was used as a negative control, the group treated with a natural antioxidant a-tocopherol and ascorbic acid, and the group treated with synthetic antioxidant BHA were used as positive control.
그 결과, 표 1에서 나타난 바와 같이, 알디시아 팅크토리아 용매 분획물은 DPPH 및 ABTS 자유라디칼 소거 효과가 뛰어남을 확인하였고, 특히 알디시아 팅크토리아 에틸아세테이트, 부탄올 분획물은 DPPH 자유라디칼 소거 효과가 현저히 높고 ABTS 자유라디칼의 경우 전 분획물에 걸쳐 소거 효과가 우수함을 확인하였다. 또한, 천연물 유래의 양성대조군인 a-토코페롤과 아스코르브산을 처리한 군과 비교하였을 때도 월등히 우수한 활성을 나타냄을 확인하였다(표 1).As a result, as shown in Table 1, the aldicia tincturea solvent fraction showed excellent DPPH and ABTS free radical scavenging effects, and especially the aldicia tincturea ethyl acetate and butanol fraction showed significantly higher DPPH free radical scavenging effect and ABTS Free radicals were found to have excellent scavenging effect over all fractions. In addition, when compared with the group treated with a-tocopherol and ascorbic acid, which are positive control groups derived from natural products, it was confirmed that they exhibited remarkably excellent activity (Table 1).
<< 제조예Manufacturing example 1> 1> 알디시아Aldishia 팅크토리아Tincture 추출물을 유효성분으로 함유하는 노화방지용 Antioxidant containing extract as active ingredient 화장료의Cosmetic 제조 Produce
<1-1> 유연 화장수의 제조<1-1> Manufacture of flexible lotion
상기 <실시예 1>의 알디시아 팅크토리아 추출물을 유효성분으로 함유하는 유연 화장수는 하기 [표 2]와 같이 제조하였다.
The softening lotion containing the aldicia tincturea extract of Example 1 as an active ingredient was prepared as shown in Table 2 below.
<1-2> 영양 크림의 제조<1-2> Preparation of nutritional cream
상기 <실시예 2>의 알디시아 팅크토리아 추출물을 유효성분으로 함유한 영양크림은 하기 [표 3]의 조성과 같이 제조하였다.
The nutritional cream containing the aldicia tincturea extract of Example 2 as an active ingredient was prepared as shown in Table 3 below.
<< 제조예Manufacturing example 2> 2> 알디시아Aldishia 팅크토리아Tincture 추출물을 유효성분으로 함유하는 약학적 제제의 제조 Preparation of Pharmaceutical Preparations Containing Extracts as Active Ingredients
<2-1> <2-1> 산제의Sanje 제조 Produce
본 발명의 알디시아 팅크토리아 추출물 2 g2 g of the aldicia tincturea extract of the present invention
유당 1 gLactose 1 g
상기의 성분을 혼합하고 기밀포에 충진하여 산제를 제조하였다.
The above components were mixed and packed in airtight bags to prepare powders.
<2-2> 정제의 제조<2-2> Preparation of tablets
본 발명의 알디시아 팅크토리아 추출물 100 ㎎100 mg of the aldicia tincturea extract of the present invention
옥수수전분 100 ㎎
유 당 100 ㎎100 mg of milk
스테아린산 마그네 2 ㎎
상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.
After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.
<2-3> 캡슐제의 제조≪ 2-3 > Preparation of capsules
본 발명의 알디시아 팅크토리아 추출물 100 ㎎100 mg of the aldicia tincturea extract of the present invention
옥수수전분 100 ㎎
유 당 100 ㎎100 mg of milk
스테아린산 마그네슘 2 ㎎2 mg of magnesium stearate
상기의 성분을 혼합한 후, 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.
After mixing the above components, the capsules were filled in gelatin capsules according to the conventional preparation method of capsules.
<2-4> 환의 제조≪ 2-4 >
본 발명의 알디시아 팅크토리아 추출물 1 g1 g of the aldicia tincturea extract of the present invention
유당 1.5 gLactose 1.5 g
글리세린 1 gGlycerin 1 g
자일리톨 0.5 g0.5 g of xylitol
상기의 성분을 혼합한 후, 통상의 방법에 따라 1환 당 4 g이 되도록 제조하였다.
After mixing the above components, they were prepared so as to be 4 g per one ring according to a conventional method.
<2-5> 과립의 제조<2-5> Preparation of granules
본 발명의 알디시아 팅크토리아 추출물 150 ㎎150 mg of the aldicia tincturea extract of the present invention
대두추출물 50 ㎎Soybean extract 50 mg
포도당 200 ㎎200 mg of glucose
전분 600 ㎎600 mg of starch
상기의 성분을 혼합한 후, 30% 에탄올 100 ㎎을 첨가하여 섭씨 60 ℃에서 건조하여 과립을 형성한 후 포에 충진하였다.
After mixing the above components, 100 mg of 30% ethanol was added and the mixture was dried at 60 캜 to form granules, which were then filled in a capsule.
<< 제조예Manufacturing example 3> 3> 알디시아Aldishia 팅크토리아Tincture 추출물을 유효성분으로 함유하는 노화방지용 건강식품의 제조 Preparation of anti-aging health food containing extract as active ingredient
<3-1> 밀가루 식품의 제조<3-1> Production of flour food
본 발명의 알디시아 팅크토리아 추출물 0.5~5.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하였다.
0.5 to 5.0 parts by weight of the aldicia tincture extract of the present invention was added to wheat flour, and the mixture was used to prepare bread, cake, cookies, crackers and noodles.
<3-2> <3-2> 스프soup 및 육즙( And juicy ( graviesgravies )의 제조)
본 발명의 알디시아 팅크토리아 추출물 0.1~5.0 중량부를 스프 및 육즙에 첨가하여 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.
0.1 to 5.0 parts by weight of the aldicia tincture extract of the present invention was added to the soup and juice to prepare a health improvement meat product, noodle soup and juice.
<3-3> 그라운드 <3-3> Ground 비프(ground beef)의Beef 제조 Produce
본 발명의 알디시아 팅크토리아 추출물 10 중량부를 그라운드 비프에 첨가하여 건강 증진용 그라운드 비프를 제조하였다.
10 parts by weight of the aldicia tincturea extract of the present invention was added to ground beef to prepare ground beef for health promotion.
<3-4> 유제품(<3-4> Dairy products ( dairydairy productsproducts )의 제조)
본 발명의 알디시아 팅크토리아 추출물 5~10 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.
5 to 10 parts by weight of the aldicia tincturea extract of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
<3-5> <3-5> 선식의Solar 제조 Produce
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and the mixture was granulated to a powder having a particle size of 60 mesh.
검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Black soybeans, black sesame seeds, and perilla seeds were steamed and dried by a conventional method, and then they were prepared into powder having a particle size of 60 mesh by a pulverizer.
본 발명의 알디시아 팅크토리아 추출물을 진공 농축기에서 감압농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.The aldicia tincture extract of the present invention was concentrated under reduced pressure in a vacuum concentrator, dried by spraying, and dried with a hot-air drier, and the resulting dried product was pulverized to a size of 60 mesh with a pulverizer to obtain a dry powder.
상기에서 제조한 곡물류, 종실류 및 본 발명의 알디시아 팅크토리아 추출물을 다음의 비율로 배합하여 제조하였다:The cereals, seeds and the aldicia tincturea extract of the present invention prepared above were blended in the following proportions:
곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부),(30 parts by weight of brown rice, 15 parts by weight of yulmu, 20 parts by weight of barley)
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame seeds)
본 발명의 알디시아 팅크토리아 추출물(3 중량부),The aldicia tincturea extract of the present invention (3 parts by weight)
영지(0.5 중량부),(0.5 part by weight),
지황(0.5 중량부).
Rhubarb (0.5 parts by weight).
<< 제조예Manufacturing example 4> 4> 알디시아Aldishia 팅크토리아Tincture 추출물을 유효성분으로 함유하는 노화방지용 음료의 제조 Preparation of anti-aging beverage containing extract as active ingredient
<4-1> <4-1> 건강음료의Health drink 제조 Produce
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 알디시아 팅크토리아 추출물 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.
5 g of the aldicia tincturea extract of the present invention was homogeneously mixed with a sub ingredient such as liquid fructose (0.5%), oligosaccharide (2%), sugar (2%), salt (0.5% Sterilized, and packaged in glass bottles, plastic bottles, and other small containers.
<4-2> 야채 주스의 제조<4-2> Production of vegetable juice
본 발명의 알디시아 팅크토리아 추출물 5 g을 토마토 또는 당근 주스 1,000 ㎖에 가하여 야채 주스를 제조하였다.
5 g of the aldicia tinctoria extract of the present invention was added to 1,000 ml of tomato or carrot juice to prepare vegetable juice.
<4-3> 과일 주스의 제조<4-3> Preparation of fruit juice
본 발명의 알디시아 팅크토리아 추출물 1 g을 사과 또는 포도 주스 1,000 ㎖ 에 가하여 과일 주스를 제조하였다.
1 g of the aldicia tincturea extract of the present invention was added to 1,000 ml of apple or grape juice to prepare fruit juice.
상기에서 보는 바와 같이, 본 발명의 알디시아 팅크토리아(Ardisia tinctoria) 추출물 및 이의 분획물은 우수한 항산화 효과를 나타내므로, 노화방지용 화장료 조성물, 약학적 조성물 및 건강식품용 조성물의 유효성분으로 유용하게 이용될 수 있다.
As shown above, the inventive Ardisia < RTI ID = 0.0 > tinctoria extract and fractions thereof exhibit an excellent antioxidative effect and thus can be effectively used as an active ingredient of a cosmetic composition for preventing aging, a pharmaceutical composition and a composition for health food.
Claims (9)
Ardisia tinctoria An antioxidative cosmetic composition comprising ethyl acetate or a butanol fraction as an active ingredient.
[Claim 2] The method according to claim 1, wherein the fraction is an ethyl acetate fraction or a butanol fraction obtained by suspending an aldicia tincturea extract in water and sequentially fractionating the fraction with normal-hexane, chloroform, ethyl acetate, n-butanol and water Wherein the antioxidant composition is an antioxidant.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20110063741 | 2011-06-29 | ||
| KR1020110063741 | 2011-06-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20130002943A KR20130002943A (en) | 2013-01-08 |
| KR101440483B1 true KR101440483B1 (en) | 2014-09-17 |
Family
ID=47835400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020120067900A KR101440483B1 (en) | 2011-06-29 | 2012-06-25 | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101440483B1 (en) |
-
2012
- 2012-06-25 KR KR1020120067900A patent/KR101440483B1/en active IP Right Grant
Non-Patent Citations (2)
| Title |
|---|
| 한국식품과학회지, 39권, 2호, 200~208페이지(2007.) * |
| 한국식품과학회지, 39권, 2호, 200~208페이지(2007.)* |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130002943A (en) | 2013-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
| KR102052523B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
| KR101004361B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
| KR101895572B1 (en) | Antioxidant composition comprising uldavioside A | |
| KR101447007B1 (en) | Composition for antiaging comprising the extract of Dipterocarpus obtusifolius Teijsm. Ex Miq. as an active ingredient | |
| KR101063351B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
| KR101889331B1 (en) | A composition having anti-oxidation, anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
| KR101425047B1 (en) | Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient | |
| KR101425560B1 (en) | Composition for antioxidant comprising extracts or its fractions of Elaeocarpus petiolatus as an active ingredient | |
| KR101988909B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant, anti-imflamation, and skin whitening | |
| KR101440483B1 (en) | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient | |
| KR20170000366A (en) | Composition for antioxidant, and anti-inflammation effect comprising Cirtus extract and Hylotelephium erythrostictum extract | |
| KR101416572B1 (en) | Composition for antiaging comprising extract or fractions of Mastixia arborea C.B.Clarke as an active ingredient | |
| KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
| KR101433726B1 (en) | Composition for antiaging comprising extracts or fractions of Diospyros blancoi A. DC. as an active ingredient | |
| KR102590758B1 (en) | Antioxidant or anti-inflammatory composition comprising extract of bilberry containing anthocyanidin components | |
| KR101988988B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening | |
| KR101498075B1 (en) | Composition and health functional food containing extracts of sorghum bran | |
| KR101007001B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
| KR102129461B1 (en) | A composition having anti-bacterial activity comprising Selaginella tamariscina extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
| KR102384358B1 (en) | Antibacterial Composition Comprising Non-aqueous Extract Of Red Ginseng | |
| WO2013002522A2 (en) | Anti-aging composition containing a mastixia arborea c.b.clarke extract or a fraction thereof as an active ingredient | |
| KR20220156164A (en) | Antioxidant or anti-inflammatory composition containing jujube seed extract or buckwheat leaf extract | |
| KR20230036756A (en) | Ultrahigh pressure ultrasonic extract for antioxidating, whitening and keratin exfoliation | |
| KR101989009B1 (en) | Composition for skin cell regeneration, anti-wrinkle and antioxidant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E90F | Notification of reason for final refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| FPAY | Annual fee payment |
Payment date: 20170824 Year of fee payment: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20180806 Year of fee payment: 5 |